Pharmabiz4h
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India: ...
Pharmabiz3h
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world: Our Bureau, Mumbai Thursday, November ...
Pharmabiz2h
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA: Calgary, Alberta Thursday, November 28, 2024, 18:00 Hrs [IST] Calg ...
Pharmabiz4h
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth: Our Bureau, Bengaluru Thursday, November 28, 2024, 15:15 Hrs [IST] Organisation of Pharmaceutical ...
Pharmabiz4h
Exelixis updates from sNDA for cabozantinib to treat patients with previously treated advanced neuroendocrine tumours
Exelixis updates from sNDA for cabozantinib to treat patients with previously treated advanced neuroendocrine tumours: Alameda, California Thursday, November 28, 2024, 15:30 Hrs [ ...
Pharmabiz3h
Boehringer Ingelheim launches next generation poultry vaccine in India
Boehringer Ingelheim announced the launch of the latest advancement in Marek’s disease vaccines in India. This next generation vaccine offers enhanced protection through an innovative controlled ...
Pharmabiz3h
NIHR Challenge Maternity Disparities Consortium members announced
Nine UK universities have been selected to make up the new NIHR Challenge Maternity Disparities Consortium, with the aim of tackling inequalities in maternity outcomes. The research carried out by the ...
Pharmabiz4h
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ: Saint Herblain, France Thursday, November 28, 2024, 16:00 Hrs [IST] Valneva SE, a specialty ...
Pharmabiz5h
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...
Pharmabiz6h
India’s pharma’s 79% CXOs see AI/ML as key drivers of growth: EY Parthenon–OPPI report
EY Parthenon–OPPI report: Our Bureau, Bengaluru Thursday, November 28, 2024, 13:45 Hrs [IST] EY Parthenon (EY-P ...
Pharmabiz5h
National Epilepsy Day celebrated by Epilepsy Foundation of India and the Mumbai Educational Trust
National Epilepsy Day celebrated by Epilepsy Foundation of India and the Mumbai Educational Trust: Our Bureau, Mumbai Thursday, November 28, 2024, 14:30 Hrs [IST] In a significant ...
Pharmabiz5h
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:45 Hrs [IST] Fedo.ai, an AI-driven plat ...